Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0059 | 0.1588 | 0.2913 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0689 | 0.1945 |
Brugia malayi | hypothetical protein | 0.0034 | 0.0592 | 0.1242 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0034 | 0.0592 | 0.1086 |
Schistosoma mansoni | hypothetical protein | 0.0159 | 0.5449 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0532 | 0.0976 |
Echinococcus multilocularis | DNA topoisomerase 1 | 0.0106 | 0.3384 | 0.6209 |
Schistosoma mansoni | tar DNA-binding protein | 0.0059 | 0.1588 | 0.2913 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0021 | 0.0109 | 0.02 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0059 | 0.1588 | 0.4367 |
Plasmodium vivax | topoisomerase I, putative | 0.0106 | 0.3384 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0532 | 0.1474 |
Echinococcus multilocularis | tar DNA binding protein | 0.0059 | 0.1588 | 0.2913 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0079 | 0.2353 | 0.4318 |
Toxoplasma gondii | DNA topoisomerase I, putative | 0.0106 | 0.3384 | 0.5 |
Loa Loa (eye worm) | DNA topoisomerase I | 0.0106 | 0.3384 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0032 | 0.0532 | 0.1055 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.111 | 0.3203 |
Loa Loa (eye worm) | RNA binding protein | 0.0059 | 0.1588 | 0.4631 |
Loa Loa (eye worm) | TAR-binding protein | 0.0059 | 0.1588 | 0.4631 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0276 | 1 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0034 | 0.06 | 0.1101 |
Trypanosoma cruzi | DNA topoisomerase IB, large subunit, putative | 0.0079 | 0.2353 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0036 | 0.0687 | 0.154 |
Brugia malayi | TAR-binding protein | 0.0059 | 0.1588 | 0.4367 |
Brugia malayi | DNA topoisomerase I | 0.0106 | 0.3384 | 1 |
Echinococcus granulosus | geminin | 0.0159 | 0.5449 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0071 | 0.2032 | 0.5762 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0021 | 0.0109 | 0.02 |
Schistosoma mansoni | bromodomain containing protein | 0.006 | 0.1603 | 0.2941 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0034 | 0.0592 | 0.1086 |
Schistosoma mansoni | hypothetical protein | 0.0159 | 0.5449 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0034 | 0.06 | 0.1101 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0276 | 1 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0776 | 0.2204 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0079 | 0.2353 | 0.4318 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0135 | 0.4518 | 0.5 |
Echinococcus multilocularis | geminin | 0.0159 | 0.5449 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0047 | 0.111 | 0.2869 |
Schistosoma mansoni | tar DNA-binding protein | 0.0059 | 0.1588 | 0.2913 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0592 | 0.1086 |
Echinococcus granulosus | tar DNA binding protein | 0.0059 | 0.1588 | 0.2913 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0059 | 0.1588 | 0.4631 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Brugia malayi | RNA binding protein | 0.0059 | 0.1588 | 0.4367 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0106 | 0.3384 | 0.6209 |
Schistosoma mansoni | tar DNA-binding protein | 0.0059 | 0.1588 | 0.2913 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0276 | 1 | 1 |
Trypanosoma brucei | DNA topoisomerase IB, large subunit | 0.0079 | 0.2353 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0034 | 0.0592 | 0.1086 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0021 | 0.0109 | 0.02 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0056 | 0.1471 | 0.27 |
Schistosoma mansoni | tar DNA-binding protein | 0.0059 | 0.1588 | 0.2913 |
Echinococcus granulosus | DNA topoisomerase 1 | 0.0106 | 0.3384 | 0.6209 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0135 | 0.4518 | 0.5 |
Leishmania major | DNA topoisomerase IB, large subunit | 0.0079 | 0.2353 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0047 | 0.111 | 0.3203 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0276 | 1 | 0.5 |
Plasmodium falciparum | topoisomerase I | 0.0106 | 0.3384 | 0.5 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0135 | 0.4518 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0047 | 0.111 | 0.2869 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0056 | 0.1471 | 0.27 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0846 | 0.2414 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0039 | 0.0071 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.1876 | 0.5491 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
T1/2 | 0 hr | Stability of the compound in pH 7.4 phosphate buffer at 37 degree C; No data | ChEMBL. | 1588561 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.